A previous study reported that MYL5 expression is reduced in multiple cancers, including breast cancer, colorectal cancer, esophageal cancer, gastric cancer, head and neck cancer, and leukemia, compared to corresponding normal tissues (Lv, 2023). The gene discussed is MYL5; the disease is head and neck cancer.